
The German government on Tuesday expressed "great concern" over the Israeli parliament's decision to introduce the death penalty for convicted terrorists.
"Understandably, Israel has taken a hard line against terrorism since October 7," said government spokesman Stefan Kornelius in Berlin. "However, the German government views the law passed yesterday with great concern."
Opposition to the death penalty is a fundamental feature of German policy, he said.
The German government is also concerned that such a law "would likely apply exclusively to Palestinians in the Palestinian territories," Kornelius added. "It therefore regrets the Knesset’s decision and cannot endorse it."
The Knesset, Israel's parliament, approved the bill on Monday. It provides that the death penalty or life imprisonment may be imposed for terrorist-motivated murder with the aim of destroying the State of Israel.
Israel abolished the death penalty for murder in 1954 and retained it only in exceptional cases. The execution of the German Nazi criminal Adolf Eichmann in 1962 was the last carried out in Israel.
latest_posts
- 1
Congress is running out of time to extend ACA subsidies as the GOP moves on to an alternative plan. Here's where things stand. - 2
'War is not over': Detailed diagrams of prisons found in cells of Oct. 7 terrorists - 3
New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz - 4
Figure out How to Upgrade Your Gold Speculation Portfolio: Vital Bits of knowledge and Strategies - 5
Instructions to Pick the Right Dental Expert for Teeth Substitution
The Universe of Impeccable Pearls: A Manual for Valuable Gems
Journey Travel Objections for Your Next Experience
Most loved Occasion Dish: What Makes Your Merry Table?
Miley Cyrus details her fear of paper, says fiancé Maxx Morando opens their packages outside: 'That's really why I got engaged'
Netflix’s Price Hikes Just Got Rejected by an Italian Court. Here’s Why It Matters Everywhere
AstraZeneca to invest $2 billion as part of US manufacturing push
Jersey's wellbeing score is below UK and France
Regeneron's experimental therapy combo effective in untreated cancer patients
Blue Origin's next space tourism flight will break new ground for people with disabilities











